ABVC Biopharma Inc
NASDAQ:ABVC
ABVC Biopharma Inc
NASDAQ:ABVC
Price:
1.08 USD
-6.09%
Market Closed
Updated:
May 5, 2024
Section:
Relative Value
The Relative Value of one
ABVC
stock under the Base Case scenario is
0.13
USD.
Compared to the current market price of 1.08 USD,
ABVC Biopharma Inc
is
Overvalued by 88%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ABVC
Relative Value
Base Case
0.13
USD
Overvaluation 88%
Valuation Multiples
Multiples Across Competitors
ABVC Competitors Multiples
ABVC Biopharma Inc Competitors
ABVC Biopharma Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
ABVC Biopharma Inc
NASDAQ:ABVC
|
11.4m USD | 74.8 | -1.1 | -1.5 | -1.5 | |
| CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
526.2B CAD | 0 | -145 824.1 | -810 977.1 | -810 977.1 | |
| US |
V
|
Viveon Health Acquisition Corp
NYSE-MKT:VHAQ
|
332.4B USD | 0 | -692 592.7 | -140 273.7 | -140 273.7 | |
| US |
G
|
Gould Investors LP
OTC:GDVTZ
|
304.4B USD | 0 | 0 | 0 | 0 | |
| US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | 263 524.8 | -70 424.1 | -77 926.9 | -77 525.1 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
76.2B Zac | 0 | 0 | 0 | 0 | |
| US |
|
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | 0 | 0 | 0 | |
| US |
|
Ergo Science Corp
OTC:ERGN
|
55.2B USD | 2 160.3 | -12 841.6 | -10 816.3 | -10 391 | |
| US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | 0 | -33 104.9 | -34 818.3 | -34 818.3 | |
| ID |
|
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
708.9T IDR | 15.6 | 40.3 | 28.9 | 28.9 | |
| US |
M
|
Myson Group Inc
OTC:MYSN
|
38.4B USD | 0 | 0 | 0 | 0 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
